1. Home
  2. RGR vs AVXL Comparison

RGR vs AVXL Comparison

Compare RGR & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGR
  • AVXL
  • Stock Information
  • Founded
  • RGR 1949
  • AVXL 2004
  • Country
  • RGR United States
  • AVXL United States
  • Employees
  • RGR N/A
  • AVXL N/A
  • Industry
  • RGR Ordnance And Accessories
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RGR Industrials
  • AVXL Health Care
  • Exchange
  • RGR Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • RGR 616.8M
  • AVXL 710.3M
  • IPO Year
  • RGR N/A
  • AVXL N/A
  • Fundamental
  • Price
  • RGR $37.22
  • AVXL $9.09
  • Analyst Decision
  • RGR
  • AVXL Strong Buy
  • Analyst Count
  • RGR 0
  • AVXL 2
  • Target Price
  • RGR N/A
  • AVXL $44.00
  • AVG Volume (30 Days)
  • RGR 185.6K
  • AVXL 825.3K
  • Earning Date
  • RGR 07-30-2025
  • AVXL 08-05-2025
  • Dividend Yield
  • RGR 1.94%
  • AVXL N/A
  • EPS Growth
  • RGR N/A
  • AVXL N/A
  • EPS
  • RGR 1.83
  • AVXL N/A
  • Revenue
  • RGR $534,561,000.00
  • AVXL N/A
  • Revenue This Year
  • RGR N/A
  • AVXL N/A
  • Revenue Next Year
  • RGR $1.89
  • AVXL N/A
  • P/E Ratio
  • RGR $20.32
  • AVXL N/A
  • Revenue Growth
  • RGR 0.65
  • AVXL N/A
  • 52 Week Low
  • RGR $32.74
  • AVXL $3.76
  • 52 Week High
  • RGR $46.40
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • RGR 52.42
  • AVXL 64.24
  • Support Level
  • RGR $37.28
  • AVXL $7.97
  • Resistance Level
  • RGR $37.90
  • AVXL $9.35
  • Average True Range (ATR)
  • RGR 0.68
  • AVXL 0.38
  • MACD
  • RGR 0.16
  • AVXL 0.18
  • Stochastic Oscillator
  • RGR 64.08
  • AVXL 86.10

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: